{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T02:38:44Z","timestamp":1770259124991,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"DOI":"10.7759\/cureus.102954","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:05:50Z","timestamp":1770210350000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-Myeloperoxidase (MPO)-Positive Granulomatosis With Polyangiitis Presenting With Pulmonary and Cutaneous Vasculitic Flares in End-Stage Renal Disease: A Diagnostic and Therapeutic Challenge"],"prefix":"10.7759","author":[{"given":"Yash","family":"Ranga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riddhi","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Ashong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-05011-1","article-title":"Epidemiology and genetics of granulomatosis with polyangiitis","volume":"41","author":"Banerjee P","year":"2021","unstructured":"Banerjee P, Jain A, Kumar U, Senapati S. Epidemiology and genetics of granulomatosis with polyangiitis. Rheumatol Int. 2021, 41:2069-89. 10.1007\/s00296-021-05011-1","journal-title":"Rheumatol Int"},{"key":"ref2","article-title":"Granulomatosis with polyangiitis","author":"Rout P","year":"2025","unstructured":"Rout P, Garlapati P, Qurie A. Granulomatosis with polyangiitis. StatPearls [Internet]. Treasure Island (FL), StatPearls Publishing; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki S","year":"2012","unstructured":"Lionaki S, Blyth ER, Hogan SL, et al.. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012, 64:3452-62. 10.1002\/art.34562","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04447-w","article-title":"Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study","volume":"39","author":"Kim SM","year":"2019","unstructured":"Kim SM, Choi SY, Kim SY, Kim J. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. Rheumatol Int. 2019, 39:1919-26. 10.1007\/s00296-019-04447-w","journal-title":"Rheumatol Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette JC","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al.. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65:1-11. 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1279823","article-title":"Lung vasculitis and alveolar hemorrhage: pathology","volume":"32","author":"Fishbein GA","year":"2011","unstructured":"Fishbein GA, Fishbein MC. Lung vasculitis and alveolar hemorrhage: pathology. Semin Respir Crit Care Med. 2011, 32:254-63. 10.1055\/s-0031-1279823","journal-title":"Semin Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.06.003","article-title":"Immune diffuse alveolar hemorrhage: clinical presentation and outcome","volume":"129","author":"Quadrelli S","year":"2017","unstructured":"Quadrelli S, Dubinsky D, Solis M, Yucra D, Hern\u00e1ndez M, Karlen H, Brigante A. Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med. 2017, 129:59-62. 10.1016\/j.rmed.2017.06.003","journal-title":"Respir Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone JH","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363:221-32. 10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones RB","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, et al.. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363:211-20. 10.1056\/NEJMoa0909169","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173773","article-title":"Rituximab induction and maintenance in ANCA-associated vasculitis: state of the art and future perspectives","volume":"10","author":"Treppo E","year":"2021","unstructured":"Treppo E, Binutti M, Agarinis R, De Vita S, Quartuccio L. Rituximab induction and maintenance in ANCA-associated vasculitis: state of the art and future perspectives. J Clin Med. 2021, 10:3773. 10.3390\/jcm10173773","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459207-anti-myeloperoxidase-mpo-positive-granulomatosis-with-polyangiitis-presenting-with-pulmonary-and-cutaneous-vasculitic-flares-in-end-stage-renal-disease-a-diagnostic-and-therapeutic-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:05:51Z","timestamp":1770210351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459207-anti-myeloperoxidase-mpo-positive-granulomatosis-with-polyangiitis-presenting-with-pulmonary-and-cutaneous-vasculitic-flares-in-end-stage-renal-disease-a-diagnostic-and-therapeutic-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.102954","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}